Design Therapeutics (DSGN) Shares Issued (2020 - 2026)

Design Therapeutics (DSGN) has 7 years of Shares Issued data on file, last reported at $17.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 28.65% year-over-year to $17.3 million; the trailing twelve-month figure through Mar 2026 stood at $17.3 million (up 28.65% YoY), and the FY2025 full-year result was $13.8 million, up 33.21% from the prior year.
• Shares Issued improved to $17.3 million in Q1 2026, from $13.8 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $17.3 million in Q1 2026 to a low of $5.1 million in Q1 2022.
• A 5-year average of $10.0 million and a median of $10.3 million in 2024 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued surged 101.84% in 2022 and grew 16.77% in 2024, its largest moves.
• Tracing DSGN's Shares Issued over 5 years: stood at $5.4 million in 2022, then surged by 58.65% to $8.6 million in 2023, then grew by 20.63% to $10.3 million in 2024, then jumped by 33.21% to $13.8 million in 2025, then rose by 25.86% to $17.3 million in 2026.
• Business Quant data shows DSGN's Shares Issued at $17.3 million in Q1 2026, $13.8 million in Q4 2025, and $13.9 million in Q3 2025.